Key takeaways:

The funding included $176 million given to Moderna last year and $590 million awarded in January.

HHS said an internal review showed that the program did not meet scientific standards or safety expectations.

Perspective from Amanda Jezek

HHS has terminated contracts with Moderna worth more than $700 million that were meant to fund the development of pre-pandemic influenza vaccines, including the company’s H5 bird flu vaccine candidate.

Moderna announced the funding cancellation in a press release that also reported positive interim data for its messenger RNA-based pandemic influenza vaccine candidate, mRNA-1018.

The Trump administration has canceled more than $700 in pandemic vaccine development funding. Image: Adobe Stock

The company said data from a phase 1/2 clin

See Full Page